• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经鼻给予胰岛素可使正常人和糖尿病患者发生低血糖。

Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects.

作者信息

Pontiroli A E, Alberetto M, Secchi A, Dossi G, Bosi I, Pozza G

出版信息

Br Med J (Clin Res Ed). 1982 Jan 30;284(6312):303-6. doi: 10.1136/bmj.284.6312.303.

DOI:10.1136/bmj.284.6312.303
PMID:6800439
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1495887/
Abstract

Regular or crystalline insulin with sodium glycocholate as surfactant administered intranasally to normal volunteers induced hypoglycaemia and an increase in serum immunoreactive insulin concentrations. Serum C-peptide concentrations decreased or remained unchanged. Insulin administered intravenously to three of these subjects yielded a potency ratio of 1:8 for intranasal and intravenous insulin. In four insulin-dependent diabetics a cross-over study was performed on different days, insulin being administered once intranasally and once subcutaneously in a ratio of 1:9. In these patients the intranasal insulin was more effective than the subcutaneous insulin in preventing hyperglycaemia after breakfast. In four other insulin-dependent diabetics 11-hours monitoring was performed twice on two different days, insulin being administered in divided dosage sufficient to achieve a reasonable glycaemic profile. The administration during the morning, whereas subcutaneous insulin was more effective than intranasal during the afternoon.

摘要

以甘氨胆酸钠作为表面活性剂的常规胰岛素或结晶胰岛素经鼻给予正常志愿者后,可诱发低血糖并使血清免疫反应性胰岛素浓度升高。血清C肽浓度降低或保持不变。对其中3名受试者静脉注射胰岛素后,经鼻胰岛素与静脉注射胰岛素的效价比为1:8。在4名胰岛素依赖型糖尿病患者中,于不同日期进行了一项交叉研究,胰岛素以1:9的比例经鼻给药一次、皮下给药一次。在这些患者中,经鼻胰岛素在预防早餐后高血糖方面比皮下胰岛素更有效。在另外4名胰岛素依赖型糖尿病患者中,于两个不同日期进行了两次11小时的监测,胰岛素以分次给药的方式给予,剂量足以实现合理的血糖曲线。上午给药时,经鼻胰岛素比皮下胰岛素更有效,而下午皮下胰岛素比经鼻胰岛素更有效。

相似文献

1
Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects.经鼻给予胰岛素可使正常人和糖尿病患者发生低血糖。
Br Med J (Clin Res Ed). 1982 Jan 30;284(6312):303-6. doi: 10.1136/bmj.284.6312.303.
2
A new non-invasive method for treating insulin-reaction: intranasal lyophylized glucagon.一种治疗胰岛素反应的新无创方法:鼻内冻干胰高血糖素。
Diabetologia. 1990 Nov;33(11):671-4. doi: 10.1007/BF00400568.
3
Intranasal glucagon treatment relieves hypoglycaemia in children with type 1 (insulin-dependent) diabetes mellitus.鼻内注射胰高血糖素治疗可缓解1型(胰岛素依赖型)糖尿病患儿的低血糖症状。
Diabetologia. 1993 Oct;36(10):931-5. doi: 10.1007/BF02374475.
4
Intranasal insulin therapy: the clinical realities.
Diabetologia. 1995 Jun;38(6):680-4. doi: 10.1007/BF00401839.
5
Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects.经鼻给予胰岛素可使正常人和糖尿病患者发生低血糖。
Br Med J (Clin Res Ed). 1982 Jun 5;284(6330):1707-8. doi: 10.1136/bmj.284.6330.1707-c.
6
[Clinical consequences of intranasal insulin therapy in insulin-dependent diabetes mellitus].[胰岛素依赖型糖尿病鼻内胰岛素治疗的临床后果]
Ugeskr Laeger. 1996 Jun 10;158(24):3451-5.
7
Human insulin plus sodium glycocholate in a nasal spray formulation: improved bioavailability and effectiveness in normal subjects.
Diabete Metab. 1987 Jul-Aug;13(4):441-3.
8
Insulin administered intranasally as an insulin-bile salt aerosol. Effectiveness and reproducibility in normal and diabetic subjects.胰岛素以胰岛素-胆盐气雾剂形式经鼻给药。在正常和糖尿病受试者中的有效性和可重复性。
Diabetes. 1983 Nov;32(11):1040-7. doi: 10.2337/diab.32.11.1040.
9
[Intranasal glucagon in the treatment of hypoglycemia. A therapeutic possibility in the future].
Ugeskr Laeger. 1994 Jul 25;156(30):4339-42.
10
Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.与强化皮下注射方案相比,胰岛素依赖型糖尿病患者采用植入式泵治疗时的餐后胰岛素曲线可能解释了严重低血糖发生频率的降低。
Am J Med. 1996 Apr;100(4):412-7. doi: 10.1016/S0002-9343(97)89516-2.

引用本文的文献

1
Efficacy of intranasal insulin in improving cognition in mild cognitive impairment or dementia: a systematic review and meta-analysis.鼻内胰岛素改善轻度认知障碍或痴呆患者认知功能的疗效:一项系统评价和荟萃分析。
Front Aging Neurosci. 2022 Sep 12;14:963933. doi: 10.3389/fnagi.2022.963933. eCollection 2022.
2
Glucagon as a Therapeutic Approach to Severe Hypoglycemia: After 100 Years, Is It Still the Antidote of Insulin?胰高血糖素治疗严重低血糖症:100 年后,它仍是胰岛素的解毒剂吗?
Biomolecules. 2021 Aug 27;11(9):1281. doi: 10.3390/biom11091281.
3
Therapeutic Use of Intranasal Glucagon: Resolution of Hypoglycemia.鼻腔给予胰高血糖素的治疗用途:低血糖的解决。
Int J Mol Sci. 2019 Jul 25;20(15):3646. doi: 10.3390/ijms20153646.
4
Insulin in the nervous system and the mind: Functions in metabolism, memory, and mood.神经系统和大脑中的胰岛素:在新陈代谢、记忆和情绪方面的功能。
Mol Metab. 2016 Jun 29;5(8):589-601. doi: 10.1016/j.molmet.2016.06.011. eCollection 2016 Aug.
5
Intranasal glucagon: a promising approach for treatment of severe hypoglycemia.鼻内注射胰高血糖素:治疗严重低血糖的一种有前景的方法。
J Diabetes Sci Technol. 2015 Jan;9(1):38-43. doi: 10.1177/1932296814557518. Epub 2014 Nov 10.
6
Pharmacokinetics and pharmacodynamics of intranasal insulin spray (Nasulin) administered to healthy male volunteers: infuence of the nasal cycle.给予健康男性志愿者鼻内胰岛素喷雾剂(Nasulin)的药代动力学和药效学:鼻周期的影响。
J Diabetes Sci Technol. 2008 Nov;2(6):1054-60. doi: 10.1177/193229680800200613.
7
Intranasal insulin therapy: the clinical realities.
Diabetologia. 1995 Jun;38(6):680-4. doi: 10.1007/BF00401839.
8
Intranasal administration of gentamicin in human subjects.庆大霉素在人体受试者中的鼻内给药。
Antimicrob Agents Chemother. 1983 May;23(5):778-9. doi: 10.1128/AAC.23.5.778.
9
Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects.经鼻给予胰岛素可使正常人和糖尿病患者发生低血糖。
Br Med J (Clin Res Ed). 1982 Jun 5;284(6330):1707-8. doi: 10.1136/bmj.284.6330.1707-c.
10
Intranasal glucagon raises blood glucose concentrations in healthy volunteers.经鼻给予胰高血糖素可提高健康志愿者的血糖浓度。
Br Med J (Clin Res Ed). 1983 Aug 13;287(6390):462-3. doi: 10.1136/bmj.287.6390.462-a.

本文引用的文献

1
Immunoassay of insulin with insulin-antibody precipitate.用胰岛素 - 抗体沉淀物进行胰岛素免疫测定。
Biochem J. 1963 Jul;88(1):137-46. doi: 10.1042/bj0880137.
2
Human insulin produced by recombinant DNA technology: safety and hypoglycaemic potency in healthy men.重组DNA技术生产的人胰岛素:健康男性中的安全性和降血糖效力
Lancet. 1980 Aug 23;2(8191):398-401. doi: 10.1016/s0140-6736(80)90443-2.
3
Absorption of insulin from the human small intestine.胰岛素在人体小肠中的吸收。
Diabetes. 1968 Oct;17(10):625-7. doi: 10.2337/diab.17.10.625.
4
Insulin: intestinal absorption as water-in-oil-in-water emulsions.胰岛素:作为水包油包水型乳剂的肠道吸收
Nature. 1968 Aug 24;219(5156):856-7. doi: 10.1038/219856a0.
5
Comparison of plasma levels of luteinizing hormone releasing hormone in men after intravenous or intranasal administration.
J Endocrinol. 1974 Nov;63(2):351-60.
6
Radioimmunological determination of human C-peptide in serum.血清中人类C肽的放射免疫测定。
Diabetologia. 1975 Dec;11(6):541-8. doi: 10.1007/BF01222104.
7
Development and evaluation of a glucose analyzer for a glucose controlled insulin infusion system ((Biostator).用于葡萄糖控制胰岛素输注系统(生物调节器)的葡萄糖分析仪的开发与评估
Clin Chem. 1978 Aug;24(8):1366-72.
8
Nasal absorption of insulin in dogs.犬类胰岛素的鼻腔吸收。
Diabetes. 1978 Mar;27(3):296-9. doi: 10.2337/diab.27.3.296.